Armour Thyroid

Armour thyroid (thyroid tablets, USP) is a product derived from porcine thyroid glands. Each grain contains 38 micrograms of levothyroxine (T4) and 9 micrograms of liothyronine (t3). Inactive ingredients are calcium stearate, dextrose, microcrystalline cellulose, sodium starch glycolate and opadry white. Armour Thryoid is a product of Forest Pharmaceuticals that is used as a naturally derived alternative to synthetic thyroid hormone replacement therapy using products such as levothyroxine.

Armour thyroid is made by taking a porcine thyroid and using the whole organ intact, it is ground up into powder form.

IUPAC_name = 3,5,3',5'-Tetraiodo-L-thyronine
CAS_number = 51-48-9
C=15 | H=10 | I=4 | N=1 | Na=1 | O=4
molecular_weight = 798.86 (anhydrous)
bioavailability = 49-79%
metabolism = Liver, kidney, intestinal wall
elimination_half-life = 2-7 days
excretion = Through feces
pregnancy_category = A (FDA)
legal_status = RX
routes_of_administration = Oral

Additional Reading

* Abelove WA: A new form of thyroid therapy. J Fla Med Assoc 1970; 57:19.
* Anon: Kelp diets can produce myxedema in iodine sensitive individuals. JAMA 1975; 233:9-10.
* Auf'mkolk M, Kohrle J, Gumbinger H, et al: Antihormonal effects of plant extracts: iodothyronine deiodinase of rat liver is inhibited by extracts and secondary metabolites of plants. Horm Metabol Res 1984; 16(4):188-192.
* Barkai G, Zarfin Y, Ben-Harari M, et al: In utero thyroxine therapy for the induction of fetal lung maturity: long term effects. J Perinat Med 1988; 16(2):145-8.
* Batagol RBatagol R (Ed): Australian Drug Evaluation Committee: Medicines in Pregnancy-An Australian categorisation of risk of drug use in pregnancy, 3rd. Australian Government Publishing Service, Canberra, Australia, 1996.
* Bergeron GA, Goldsmith R, & Schiller NB: Myocardial infarction, severe reversible ischemia, and shock following excess thyroid administration in a woman with normal coronary arteries. Arch Intern Med 1988; 148:1450-1453.
* Cobb WE & Jackson IMD: Drug therapy reviews: management of hypothyroidism. Am J Hosp Pharm 1978; 35:51-58.
* Cooper DS: Treatment with thyroid hormone. JAMA 1989; 262:1774-1775.
* Costigan DC, Freedman MH, & Ehrlich RM: Potentiation of oral anticoagulant effect of L-thyroxine. Clin Pediatr 1984; 23:172-174.
* Gilman AG, Rall TW, Nies AS, et al (Eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th. Pergamon Press, New York, NY, 1990a.
* Gilman AG, Rall TW, Nies AS, et alGilman AG, Rall TW, Nies AS, et al (Eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th. Pergamon Press, New York, NY, 1990.
* Hansten PD: Oral anticoagulants and drugs which alter thyroid function. Drug Intell Clin Pharm 1980; 14:331-334.
* Heinonen OP, Slone D, & Shapiro SHeinonen OP, Slone D, & Shapiro S (Eds): Birth defects and drugs in pregnancy, Publishing Sciences Group, Littleton, MA, 1977, pp 397-398.
* Hoffman DA, McConahey WM, Brinton LA, et al: Breast cancer in hypothyroid women using thyroid supplements. JAMA 1984; 251:616-619.
* Holdredge JM: Congenital goiter. A case report. Grace Hosp Bull 1962; 40:18-20.
* Hurxthal LM, Dotter WE, Vose GP, et al: Effect of postoperative hypoparathyroidism on bone density. Texas Rep Biol Med 1976; 34:257-265.
* Huston G: Thyroxine-replacement therapy, aldosterone, and cardiac failure (letter). Lancet 1979; 1:387.
* Ishizuki Y, Yamauchi K, & Miura Y: Transient thyrotoxicosis induced by Japanese Kombu. Folia Endocrinol 1989; 65:91-98.
* Jackson IMD & Cobb WE: Why does anyone still use desiccated thyroid USP?. Am J Med 1978; 64:284-288.
* Kapdi CC & Wolfe JN: Breast cancer: relationship to thyroid supplements to hypothyroidism. JAMA 1976; 236:1124-1127.
* Kaplan MM: Monitoring thyroxine treatment during pregnancy. Thyroid 1992; 2:147-152.
* Kaplan MM: Thyroid hormone therapy: what, when, and how much. Postgrad Med 1993; 93:249-262.
* Keller K, Hansel R, & Chandler RFKeller K, Hansel R, & Chandler RF (Eds): Adverse Effects of Herbal Drugs, 1, Springer-Verlag, Berlin, Germany, 1993.
* Kemper F: Experimental basis for the therapeutic use of Lithospermum officinale for blocking of anterior pituitary hormone. Arzneim Forsch 1959; 4:411-419.
* Kohrle J, Auf'mkolk M, Winterhoff H, et al: Iodothyronine deiodinases: inhibition by plant extracts. Acta Endocrinol 1981; Suppl 240:15-16.
* Lamberg BA: Endemic goiter-iodine deficiency disorders. Ann Med 1991; 23:367-72.
* Larsen PR: Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 1982; 306:23-32.
* Lev-Ran A: Part-of-the-day hypertriiodothyroninemia caused by desiccated thyroid. JAMA 1983; 250:2790-2791.
* Liu X-Q, Rahman A, Bagdade JD, et al: Effect of thyroid hormone on plasma apolipoproteins and apoA- and apoB-containing lipoprotein particles. Eur J Clin Invest 1998; 28:266-270.
* Low LC, Ratcliffe W, & and Alexander W: Intrauterine hypothyroidism due to antithyroid-drug therapy for thyrotoxicosis during pregnancy. Lancet 1978; 2:370-371.
* MacGillivray MH: Thyroid dysfunction in the neonatal period. Clin Perinatol 1975; 2:15-21.
* Man EB & Serunian SA: Thyroid function in human pregnancy. IX. Development or retardation of 7-year-old progeny of hypothyroxinemic women. Am J Obstet Gynecol 1976; 125(7):949.
* Man EB, Jones WS, Holden RH, et al: Thyroid function in human pregnancy. 8. Retardation of progeny aged 7 years; relationships to maternal age and maternal thyroid function. Am J Obstet Gynecol 1971; 111(7):905-16.
* Man EB: Studies of children born to women with thyroid disease. Am J Obstet Gynecol 1958; 75:728-741.
* Marks P, Anderson J, & Vincent R: Aldosterone in myxoedema. Lancet 1978; 2:1277-1278.
* Matsuura K, Mizumoto J, Matsui K, et al: Pregnancy following combined therapy with thyroid hormone and bromocriptine in a patient with amenorrhea-galactorrhea due to primary hypothyroidism. Int J Fertil 1982; 27:181-183.
* Mustacchi P & Greenspan F: Thyroid supplementation for hypothyroidism. An latrogenic cause of breast cancer?. JAMA 1977; 237:1446-1447.
* Norman JA, Pickford CJ, Sanders TW, et al: Human intake of arsenic and iodine from seaweed-based food supplements and health foods available in the UK. Food Add Contamin 1987; 5:103-109.
* Okamura K, Inoue K, & Omae T: A case of Hashimoto's thyroiditis with thyroid immunological abnormality manifested after habitual ingestion of seaweed. Acta Endocrinol 1978; 88:703-712.
* Olgaard K & Borup K: Aldosterone in myxoedema (letter). Lancet 1979; 1:218.
* Olin B (Ed): Facts and Comparisons, JB Lippincott Co, St Louis, MO, 1990a.
* Oppenheimer JH: Thyroid hormone action at the nuclear level. Ann Intern Med 1985; 102:374-384.
* Pandya AG, Beaudoing DL, & Tharp MD: Chronic urticaria associated with exogenous thyroid use (letter). Arch Dermatol 1990; 126:1238-1239.
* Penny R & Frasier SD: Elevated serum concentrations of triiodothyronine in hypothyroid patients. Values for patients receiving VSP thyroid. Am J Dis Child 1980; 134:16-28.
* Piggott TA, Pato MT, & L'Heureux F: A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder. J Clin Psychopharmacol 1991; 11:242-248.
* Potter JD: Hypothyroidism and reproductive failure. Surg Gynecol Obstet 1980; 150:251-255.
* Product Information: ARMOUR(R) THYROID oral tablets, thyroid oral tablets. Forest Laboratories,Inc, St. Louis, MO, 2002.
* Rayburn WF: Chronic medical disorders during pregnancy. Guidelines for prescribing drugs. J Reprod Med 1997; 42(1):1-24.
* Reynolds JEF (Ed): Martindale: The Extra Pharmacopoeia, (electronic version). Micromedex, Inc. Denver, CO. 1990.
* Rice AJ, McIntosh TJ, Fouts JR, et al: Decreased sensitivity to warfarin in patients with myxedema. Am J Med Sci 1971; 262:211-215.
* Riley ED & and Sclare G: Thyroid disorders in the newborn. Br Med J 1957; 1:979-980.
* Schoen HC, Lund MH, & Catz B: Clinical and laboratory response to different thyroid substitution medications. Am J Med Sci 1970; 260:299-307.
* Self T, Weisburst M, Wooten E, et al: Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism. JAMA 1975; 231:1165-1166.
* Self TH, Straughn AB, & Weisburst MR: Effect of hyperthyroidism on hypoprothrombinemic response to warfarin. Am J Hosp Pharm 1976; 33:387-389.
* Shapiro S, Slone D, Kaufman DW, et al: Use of thyroid supplements in relation to the risk of breast cancer. JAMA 1980; 244:1685-1687.
* Shilo S & Hirsch HJ: Iodine-induced hyperthyroidism in a patient with a normal thyroid gland. Postgrad Med J 1986; 62(729):661-662.
* Smith SR: Desiccated thyroid preparations: obsolete therapy. Arch Intern Med 1984; 144:926-927.
* Sourgens H, Winterhoff H, Gumbinger HG, et al: Antihormonal effects of plant extracts on hypophyseal hormones in the rat. Acta Endocrinol 1980b; 234(suppl):49.
* Sourgens H, Winterhoff H, Gumbinger HG, et al: Antihormonal effects of plant extracts. TSH- and prolactin-suppressing properties of Lithospermum officinale and other plants. Planta Medica 1982; 45(2):78-86.
* Sourgens H: Further investigations on the mechanism of action of freeze dried extracts of Lithospermum officinale L. (abstract). Naun Schmied Arch Pharmacol 1979; 307(suppl):201.
* Stephens MA, Self TH, Lancaster D, et al: Hypothyroidism: effect on warfarin anticoagulation. South Med J 1989; 82:1585-1586.
* Tajiri J, Higashi K, Morita M, et al: Studies of hypothyroidism in patients with high iodine intake. J Clin Endocrinol Metab 1986; 63:412-417.
* Tanis BC, Westendorp RGJ, & Smelt HM: Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol 1996; 44:643-649.
* Taylor S, Kapur M, & Adie R: Combined thyroxine and triiodothyronine for thyroid replacement therapy. Br Med J 1970; 2:270.
* Thompson JA & Riley ID: Neonatal thyrotoxicosis associated with maternal hypothyroidism. Lancet 1966; 1:635-636.
* Trence D: Thyroid replacement therapy: guidelines for use in therapy and diagnosis. Postgrad Med 1983; 73:367.
* Uzzan B, Campos J, & Cucherat M etal: Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 1996; 81:4278-4289.
* Vagenakis AG, Cote R, Miller ME, et al: Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis. Johns Hopkins Med J 1972; 131:69-73.
* Wagner VH, Horhammer L, & Frank U: Lithospermic acid, the antihormonally active principle of Lycopus europaes L. and Symphytum officinale L. Arzneimittelforschung 1970; 20(5):705-712.
* Weider DJ & Parker W: Lingual thyroid: review, case reports, and therapeutic guidelines. Ann Otol Rhinol Laryngol 1977; 86:841-848.
* Winterhoff H, Gumbinger HG, & Sourgens H: On the antigonadotropic activity of Lithospermum and Lycopus species and some of their phenolic constituents. Planta Medica 1988; 54:101-106.
* Winterhoff H, Sourgens H, & Kemper FH: Pharmacodynamic effects of Lithospermum officinale on the thyroid gland of rats; comparison with the effects of iodide. Horm Metabol Res 1983; 15(10):503-507.
* Yamaguchi K, Fukushima H, Uzawa H, et al: A case of iodide myxedema observed for three years under a low iodide diet-especially on the restoration of the escape mechanism from the Wolff-Chaikoff Effect. Folia Endocrinol 1984; 60:79-88.

Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Armour (disambiguation) — Armour or armor (American spelling) is protective clothing for combat. Other meanings include:Military:* Armoured forces, heavy cavalry, or tank units * Vehicle armour, protecting armoured fighting vehicles or warships * Belt armor of battleships …   Wikipedia

  • Thyroid hormone resistance — MedlinePlus = eMedicineSubj = eMedicineTopic = MeshID = D018382 Thyroid hormone resistance describes a rare syndrome where the thyroid hormone levels are elevated but the thyroid stimulating hormone (TSH) level is not suppressed, or not… …   Wikipedia

  • Thyroid hormone — The thyroid hormones, thyroxine (T4) and triiodothyronine (T3), are tyrosine based hormones produced by the thyroid gland. An important component in the synthesis is iodine. The major form of thyroid hormone in the blood is thyroxine (T4). The… …   Wikipedia

  • Armour and Company — was an American slaughterhouse and meatpacking company founded in Chicago, Illinois, in 1867 by the Armour brothers, led by Philip Danforth Armour. By 1880, the company was Chicago s most important business and helped make the city and its Union… …   Wikipedia

  • Armour — Ar·mour (ahrґmər) trademark for a preparation of porcine thyroid, which contains levothyroxine and liothyronine …   Medical dictionary

  • Desiccated thyroid extract — Combination of Levothyroxine Thyroid hormone Liothyronine Thyroid hormone Clinical data Pregnancy cat. A Legal status ℞ only …   Wikipedia

  • Hormona tiroidea — Tiroxina (T4) Triyodotironina (T …   Wikipedia Español

  • Forest Laboratories — is a pharmaceutical company headquartered in New York City, USA. Its revenues for the year ended 31 March 2007 were US$3.4 billion. The company s research development spending has grown rapidly in recent years, and as of 2007, approached almost a …   Wikipedia

  • Pendrin — also known as solute carrier family 26, member 4 or SLC26A4, is a human gene.cite web | title = Entrez Gene: SLC26A4 solute carrier family 26, member 4| url = Cmd=ShowDetailView TermToSearch=5172|… …   Wikipedia

  • Pendred syndrome — Classification and external resources OMIM 274600 DiseasesDB 9771 GeneReviews …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.